Nanomicellar Paclitaxel Increases Cytotoxicity of Multidrug Resistant Breast Cancer Cells

Cancer Letters - Ireland
doi 10.1016/j.canlet.2008.09.041
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Different Administration Strategies With Paclitaxel Induce Distinct Phenotypes of Multidrug Resistance in Breast Cancer Cells

Cancer Letters
Cancer ResearchOncology
2013English

Inhibition of Synuclein-Γ Expression Increases the Sensitivity of Breast Cancer Cells to Paclitaxel Treatment

International Journal of Oncology
Cancer ResearchOncology
2006English

Forskolin Increases the Effect of Everolimus on Aromatase Inhibitor-Resistant Breast Cancer Cells

Oncotarget
Oncology
2018English

Mechanism of Action of Substituted Indanones in Multidrug Resistant Breast Cancer

2000English

Mechanism of Action of Substituted Indanones in Multidrug Resistant Breast Cancer

2001English

Paclitaxel in Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
1998English

Emodin Sensitizes Paclitaxel-Resistant Human Ovarian Cancer Cells to Paclitaxel-Induced Apoptosis in Vitro

Oncology Reports
MedicineCancer ResearchOncology
2009English

Trafficking Microenvironmental pHs of Polycationic Gene Vectors in Drug-Sensitive and Multidrug-Resistant McF7 Breast Cancer Cells

Biomaterials
Mechanics of MaterialsBiophysicsBiomaterialsBioengineeringCompositesNanoscienceNanotechnologyCeramics
2010English

Responsive Nanomicellar Theranostic Cages for Metastatic Breast Cancer

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy